Modeling the Cost and Health Impacts of Diagnostic Strategies in Patients with Suspected Transthyretin Cardiac Amyloidosis

Modeling the Cost and Health Impacts of Diagnostic Strategies in Patients with Suspected Transthyretin Cardiac Amyloidosis

Background Transthyretin cardiac amyloidosis (ATTR‐CMP) is an increasingly recognized and treatable cause of heart failure with preserved ejection fraction. Multimodality cardiac imaging is recommended for ATTR‐CMP diagnosis, but its cost‐effectiveness in current clinical practice has not been well...

Full description

Bibliographic Details
Main Authors: Yin Ge, Ankur Pandya, Sarah A. M. Cuddy, Amitoj Singh, Avinainder Singh, Sharmila Dorbala
Format: Article
Language:English
Published: Wiley 2022-09-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
cardiac amyloidosis
cost–benefit analysis
multimodal imaging
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.122.026308

Similar Items

Similar Items